MARKET

ARDX

ARDX

Ardelyx
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.89
+0.14
+2.43%
Opening 11:10 04/06 EDT
OPEN
6.00
PREV CLOSE
5.75
HIGH
6.00
LOW
5.82
VOLUME
94.50K
TURNOVER
--
52 WEEK HIGH
8.82
52 WEEK LOW
2.100
MARKET CAP
523.80M
P/E (TTM)
-3.9736
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ARDX stock price target is 13.00 with a high estimate of 15.00 and a low estimate of 11.00.

EPS

ARDX News

More
  • Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors
  • PR Newswire · 03/16 14:00
  • Tocagen's Upswing, And Other News: The Good, Bad And Ugly Of Biopharma
  • Seeking Alpha - Article · 03/10 09:36
  • Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
  • Simply Wall St. · 03/09 13:15
  • Ardelyx (ARDX) Reports Q4 Loss, Tops Revenue Estimates
  • Zacks · 03/06 22:15

Industry

Biotechnology & Medical Research
+4.10%
Pharmaceuticals & Medical Research
+3.18%

Hot Stocks

Symbol
Price
%Change

About ARDX

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. It operates through the research, development and commercialization of biopharmaceutical products segment. The Company's products line includes cardiorenal portfolio and gastrointestinal portfolio. The Company's cardiorenal portfolio includes two Phase III clinical product candidates, tenapanor in Phase III clinical development for treating hyperphosphatemia in end-stage renal disease (ESRD) patients on dialysis and RDX7675 in Phase III clinical development for treating hyperkalemia in chronic kidney disease (CKD) and heart failure patients. The cardiorenal portfolio includes tenapanor, RDX7675, RDX013 and RDX011. Its gastrointestinal portfolio is led by tenapanor for the treatment of irritable bowel syndrome with constipation (IBS-C). The gastrointestinal portfolio includes tenapanor, RDX8940, RDX011 and RDX023.
More

Webull offers kinds of Ardelyx Inc stock information, including NASDAQ:ARDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARDX stock news, and many more online research tools to help you make informed decisions.